- Report
- August 2025
- 382 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 278 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 369 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 274 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 138 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 288 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 375 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 227 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 390 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 370 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 375 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 380 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 271 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 387 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 377 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 383 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 466 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 170 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 221 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 242 Pages
Global
From €5205EUR$5,850USD£4,494GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more